Latest Blog Posts Tagged "Pre-clinical"
August 24, 2016
To keep you informed of the Foundation's research investments, we're highlighting a few newly funded grants supporting the development of therapies to address common non-motor symptoms of Parkinson's.
April 24, 2014
A new funding program aims to explore which species of the protein alpha-synuclein play a role in the clumps seen in Parkinson's disease.
September 13, 2013
The MJFF Research Tools Program recently marked some milestones in the ongoing effort to strategically grow the MJFF tools catalogue and improve understanding of current tools and their utility.
May 17, 2012
Today, The Michael J. Fox Foundation launches its new video series "The Parkinson's Minute", featuring Patient Council member and public broadcasting producer Dave Iverson.
May 09, 2012
This week, Envoy Therapeutics announced a second grant from The Michael J. Fox Foundation (MJFF) for the ongoing development of an oral drug aimed at alleviating the symptoms of Parkinson's disease.
March 09, 2012
It's long been understood that the motor symptoms of Parkinson's disease (PD) stem from a loss of dopamine-producing cells in the brain.
December 20, 2011
Today, MJFF awardee ProteoTech, Inc., a privately held biotechnology company, announced a funding agreement with GlaxoSmithKline (China) R&D Company Limited (GSK) to collaborate on ProteoTech's therap...
November 10, 2011
MJFF continues to work to address research focused on the unmet needs of people living Parkinson's disease (PD) today. The Foundation's partnership with Jim Greene, MD, PhD, of Emory University addre...